LPP Antibodies

Santa Cruz Biotechnology features a diverse variety of LPP Antibodies for research applications. Monoclonal LPP Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LPP, or lipoma-preferred partner, is a protein that plays a critical role in cellular processes such as cell adhesion, migration, and signaling. LPP has emerged as a significant focus in cancer research due to its involvement in tumor progression and metastasis. Understanding LPP function can provide insights into various pathological conditions and potential therapeutic targets. Monoclonal LPP Antibodies enable precise detection and analysis of LPP expression patterns across different cell types and tissues. Researchers can utilize LPP Antibodies to investigate cellular dynamics and disease mechanisms with high specificity. Advanced research techniques incorporating LPP Antibodies help reveal new pathways and molecular interactions. Santa Cruz Biotechnology monoclonal LPP Antibodies support scientists worldwide in advancing our understanding of cellular biology and disease mechanisms.